Sign up to save your podcasts
Or
Share Real-World Decision Points in Biomarker-Driven NSCLC Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Real-World Decision Points in Biomarker-Driven NSCLC Management
Dr Jamie Chaft discusses how longitudinal biomarker assessment can support treatment planning, resistance evaluation, and rebiopsy decision-making in NSCLC. Key topics include disease progression, tissue limitations, prior assay results, multidisciplinary collaboration, and individualized testing strategies.
View all episodes
By HMP GlobalDr Jamie Chaft discusses how longitudinal biomarker assessment can support treatment planning, resistance evaluation, and rebiopsy decision-making in NSCLC. Key topics include disease progression, tissue limitations, prior assay results, multidisciplinary collaboration, and individualized testing strategies.